A Study to Describe Pain Intensity, Pain Relief and Safety of Neosaldina in the Treatment of Tension-type Headaches (TTH) in Healthy Participants

NCT03666858 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 216

Last updated 2021-06-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to describe pain relief in TTH with Neosaldina treatment.

Conditions

  • Healthy Volunteers
  • Tension-type Headache

Sponsors & Collaborators

Principal Investigators

  • Medical Director · Takeda

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-20
Primary Completion
2019-07-05
Completion
2019-08-19

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03666858 on ClinicalTrials.gov